About: Saratoga Opthalmology

Investigators compared the preferred practice of treating amblyopia with sequential treatment (glasses, then occlusion) with simultaneous treatment (glasses and occlusion together). Source: AAO

• Posted on: Feb 25 2022
• By: Saratoga Opthalmology
• Leave a reponse

This case series found that gonioscopy-assisted transluminal trabeculotomy (GATT) in eyes with a history of prior corneal transplant resulted in fewer complications than other surgical approaches. Source: AAO

• Posted on: Feb 24 2022
• By: Saratoga Opthalmology
• Leave a reponse

Investigators in Japan conducted a retrospective cohort analysis to identify risk factors for epiretinal membrane (ERM) formation following pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD) repair. Source: AAO

• Posted on: Feb 24 2022
• By: Saratoga Opthalmology
• Leave a reponse

Faricimab was approved by the FDA in January 2022 for the treatment of neovascular AMD and diabetic macular edema (DME). This approval was partially based on 2 phase 3 studies, which also showed the potential to extend the time between treatments. Source: AAO

• Posted on: Feb 23 2022
• By: Saratoga Opthalmology
• Leave a reponse

This subanalysis of the FAST trial, which compared methotrexate and mycophenolate mofetil in noninfectious uveitis, evaluated time to corticosteroid-sparing control of inflammation. Source: AAO

• Posted on: Feb 23 2022
• By: Saratoga Opthalmology
• Leave a reponse

Liposomal ozonized oil plus hypromellose is a potential new option beyond povidine iodine to reduce bacterial flora load and the potential risk for endophthalmitis in cataract surgery. Source: AAO

• Posted on: Feb 21 2022
• By: Saratoga Opthalmology
• Leave a reponse

This week in the news, disparities in ophthalmic care between North American Native and White populations remain, migraine sufferers have a high risk of neovascular AMD, and thinner RNFL and GCL thickness may be a biomarker for early cognitive decline. Source: AAO

• Posted on: Feb 21 2022
• By: Saratoga Opthalmology
• Leave a reponse

Patients with diabetic macular edema (DME) who stopped anti-VEGF treatment for several months recovered vision and anatomic outcomes when treatment was resumed. Source: AAO

• Posted on: Feb 16 2022
• By: Saratoga Opthalmology
• Leave a reponse

According to the World Heart Federation (WHF), no amount of alcohol consumption is safe, and there is no evidence confirming any benefits of alcohol. Source: AAO

• Posted on: Feb 15 2022
• By: Saratoga Opthalmology
• Leave a reponse

This week, a new video game aids in AMD detection, thinner RNFL thickness is seen in patients with both diabetes and hypertension, and safer options for conducting in-person IOP measurements are reviewed. Source: AAO

• Posted on: Feb 14 2022
• By: Saratoga Opthalmology
• Leave a reponse